Physician

Michael Park, MD

According to 2025 Medicare claims, Michael Park, MD (NPI: 1831611177) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07666-1704. Park is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Park's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 9,110 HCPCS/CPT codes, and received $1,227,897 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 635 prescription claims across 180 beneficiaries totaling $31,248 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 26 records totaling $644. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $9,201 to $31,248. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$614K$1.2M2022 Medicare payment: $2,013 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $278,011 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,227,897 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20224751$2,013
20233292,570$278,011
20246369,110$1,227,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$38K2019 Drug cost: $9,201 (USD; Tot_Drug_Cst)2020 Drug cost: $9,109 (USD; Tot_Drug_Cst)2021 Drug cost: $9,491 (USD; Tot_Drug_Cst)2022 Drug cost: $33,698 (USD; Tot_Drug_Cst)2023 Drug cost: $37,698 (USD; Tot_Drug_Cst)2024 Drug cost: $31,248 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195279$9,201
20203472$9,109
202168203$9,491
2022140594$33,698
2023150610$37,698
2024180635$31,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more179179$116
92014Established patient complete exam of visual system436888$104
92134Imaging of retina478953$34
92250Photography of the retina209212$30
92202Extended exam of the back part of the eye with optic nerve drawing366704$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium25470$8,489
Prednisolone AcetatePrednisolone Acetate1766,037$6,576
Bromfenac SodiumBromfenac Sodium22415$3,655
Ketorolac TromethamineKetorolac Tromethamine681,865$1,963
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat413,127$775

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$644Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Park, MD?

Tedicare shows public-source Medicare data for Michael Park, MD (NPI 1831611177), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Park, MD have ACO affiliation data?

Michael Park, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Michael Park, MD?

Michael Park, MD is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Michael Park, MD have Open Payments data?

Michael Park, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.